Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G G Wulf

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Blood|August 9, 2001
A leukemic stem cell with intrinsic drug efflux capacity in acute myeloid leukemiaG G Wulf, R Y Wang, I Kuehnle, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 13, 2017
Refractory or relapsed aggressive B-cell lymphoma failing (R)-CHOP: an analysis of patients treated on the RICOVER-60 trialB Glass, A J Dohm, L H Truemper, et al.
Bone Marrow Transplantation|September 28, 2010
Radioimmunotherapy with (90)Y-ibritumomab tiuxetan is a safe and efficient treatment for patients with B-cell lymphoma relapsed after auto-SCT: an analysis of the international RIT-NetworkK Hohloch, P L Zinzani, W Linkesch, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 24, 2004
A distinct "side population" of cells with high drug efflux capacity in human tumor cellsC Hirschmann-Jax, A E Foster, G G Wulf, et al.
Leukemia|May 9, 2008
Intracellular ABC transporter A3 confers multidrug resistance in leukemia cells by lysosomal drug sequestrationB Chapuy, R Koch, U Radunski, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Blood|August 9, 2001
A leukemic stem cell with intrinsic drug efflux capacity in acute myeloid leukemiaG G Wulf, R Y Wang, I Kuehnle, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 13, 2017
Refractory or relapsed aggressive B-cell lymphoma failing (R)-CHOP: an analysis of patients treated on the RICOVER-60 trialB Glass, A J Dohm, L H Truemper, et al.
Bone Marrow Transplantation|September 28, 2010
Radioimmunotherapy with (90)Y-ibritumomab tiuxetan is a safe and efficient treatment for patients with B-cell lymphoma relapsed after auto-SCT: an analysis of the international RIT-NetworkK Hohloch, P L Zinzani, W Linkesch, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 24, 2004
A distinct "side population" of cells with high drug efflux capacity in human tumor cellsC Hirschmann-Jax, A E Foster, G G Wulf, et al.
Leukemia|May 9, 2008
Intracellular ABC transporter A3 confers multidrug resistance in leukemia cells by lysosomal drug sequestrationB Chapuy, R Koch, U Radunski, et al.
Pageof 3